Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
European Journal of Nuclear Medicine and Molecular Imaging
Published in: European Journal of Nuclear Medicine and Molecular Imaging 1/2023

11-08-2023 | Editorial

Strategy planning for turbulent times in nuclear medicine: Time to begin at the beginning?

Authors: Rayjanah Allie, Irfan Kayani, Gopinath Gnanasegaran, Sobhan Vinjamuri, Arturo Chiti, Diana Paez, Francesco Giammarile, Ken Herrmann, Jamshed Bomanji

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 1/2023

Login to get access

Excerpt

Strategy planning in nuclear medicine imaging in uncertain times can be a challenging task. In the traditional strategic-planning model, managers attempt to forecast how the imaging landscape will evolve and how competitors will respond. They then define a multi-year plan to position their departments in this envisaged future state. That model worked well when the health landscape and economies were more stable, and the primary factors influencing future growth and expansion were easier to forecast. However, the world and the health landscape are changing so quickly that no service can plan for every eventuality. …
Literature
1.
Prakash A, Jha SK, Mohanty R. Scenario planning for service quality: a Monte Carlo simulation study. J Strateg Manag. 2012;5(3):331–52.
2.
Li M, Garrison L Jr, Lee W, Kowal S, Wong W, Veenstra D. A pragmatic guide to assessing real option value for medical technologies. Value Health. 2022; 22:S1098–3015(22)02002–2.
3.
4.
5.
6.
Bohr A, Memarzadeh K. The rise of artificial intelligence in healthcare applications. Artif Intell Healthcare. 2020:25–60 In Principles of Gender-Specific Medicine Sex and Gender-Specific Biology in the Postgenomic Era, Elsevier Science 2023
7.
Bowman EH, Moskowitz GT. Real options analysis and strategic decision making. Organ Sci. 2001;12(6):772–7.CrossRef
8.
9.
Changing Mindsets to Realize the 2030. How to promote new mindsets and behaviours in public institutions to implement the Sustainable Development Goals. Agenda for Sustainable Development. United Nations Department of Economic and Social Affairs, New York. 2021. Accessed 2 Jul 2023.
10.
Huang HL, Gnanasegaran G, Paez D, Fanti S, Hacker M, Sathekge M, Bom HS, Cerci JJ, Chiti A, Lan X, Herrmann K, Scott AM, Vinjamuri S, Dorbala S, Estrada E, Pellet O, Orellana P, El-Haj N, Giammarile F, Abdel-Wahab M, Bomanji J. Correction to: nuclear medicine services after COVID-19: gearing up back to normality. Eur J Nucl Med Mol Imaging. 2020;47(9):2220 (Erratum for: Eur J Nucl Med Mol Imaging. 2020 Aug;47(9):2048-2053).CrossRefPubMedPubMedCentral
11.
Gnanasegaran G, Paez D, Sathekge M, Giammarile F, Fanti S, Chiti A, Bom H, Vinjamuri S, Pascual TN, Bomanji J. Coronavirus (COVID-19) pandemic mediated changing trends in nuclear medicine education and training: time to change and scintillate. Eur J Nucl Med Mol Imaging. 2022;49(2):427–35 (Erratum in: Eur J Nucl Med Mol Imaging. 2022 Dec;50(1):234).CrossRefPubMed
12.
Graham R, Moreira AP, Glaudemans AWJM, Jensen LT, Mihaïlovic J, Nazarenko S, Ozcan Z, Piciu D, Wadsak W, Kunikowska J, Jamar F. 2022 follow-up: impact of the COVID-19 pandemic on nuclear medicine departments in Europe. Eur J Nucl Med Mol Imaging. 2022;49(10):3309–15.CrossRefPubMedPubMedCentral
13.
Allam Z, Bibri SE, Sharpe SA. The rising impacts of the COVID-19 pandemic and the Russia-Ukraine war: energy transition, climate justice, global inequality, and supply chain disruption. Resources. 2022;11:99.CrossRef
14.
Brindis RG, Douglas PS, Hendel RC, American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American Society of Nuclear Cardiology, American Heart Association, et al. ACCF/ASNC appropriateness criteria for single-photon emission computed tomography myocardial perfusion imaging (SPECT MPI): a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group and the American Society of Nuclear Cardiology endorsed by the American Heart Association. J Am Coll Cardiol. 2005;46(8):1587–605.CrossRefPubMed
15.
16.
Kamel SI, Intenzo CM, Parker L, Rao V, Levin DC. Recent trends suggest possible inappropriate utilization of myocardial perfusion imaging. J Am Coll Radiol. 2019;16(8):1013–7.CrossRefPubMed
17.
Kumar R. Real options valuation. In: Valuation: theories and concepts. London: Academic Press. In Valuation, Theories and Concepts Academic Press Elsevier Inc 2016, p. 227–236.
18.
Glantz M, Mun J. Strategic real options analysis: managing risk through flexibility. In: Credit engineering for bankers. 2nd ed. Burlington: Academic Press. Elsevier Inc 2011, p. 295–308.
19.
Krenning EP, Kwekkeboom DJ, Bakker WH, et al. Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients. Review Eur J Nucl Med. 1993;20:716–31.CrossRefPubMed
20.
21.
Brownell GL. A history of positron imaging. Presented at the Celebration of the 50th Year of Services to the Massachusetts General Hospital, Cambridge, MA. 1999. https://​websites.​umich.​edu. Accessed 8 Jul 2023.
22.
Beyer T, Townsend DW, Brun T, et al. A combined PET/CT scanner for clinical oncology. J Nucl Med. 2000;41:1369–79.PubMed
23.
24.
Metadata
Title
Strategy planning for turbulent times in nuclear medicine: Time to begin at the beginning?
Authors
Rayjanah Allie
Irfan Kayani
Gopinath Gnanasegaran
Sobhan Vinjamuri
Arturo Chiti
Diana Paez
Francesco Giammarile
Ken Herrmann
Jamshed Bomanji
Publication date
11-08-2023
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 1/2023
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-023-06379-x

Other articles of this Issue 1/2023

European Journal of Nuclear Medicine and Molecular Imaging 1/2023 Go to the issue

Editorial

How to attract young talent to nuclear medicine step 1: a survey conducted by the EANM Oncology and Theranostics Committee to understand the expectations of the next generation

Short Communication

The potential role of osteoporosis in unspecific [18F]PSMA-1007 bone uptake

Original Article

Integrated myocardial flow reserve (iMFR) assessment: diffuse atherosclerosis and microvascular dysfunction are more strongly associated with mortality than focally impaired perfusion

Original Article

Preclinical evaluation of a dual-receptor targeted tracer [68Ga]Ga-HX01 in 10 different subcutaneous and orthotopic tumor models

Original Article

Direct comparison and reproducibility of two segmentation methods for multicompartment dosimetry: round robin study on radioembolization treatment planning in hepatocellular carcinoma

Editorial

EANM position paper: theranostics in brain tumours—the present and the future